31/05/2024 - 15:30

Shares rise following Thurn return

31/05/2024 - 15:30


Save articles for future reference.

Shares in Perth biotech company PharmAust rose by 14 per cent on Friday to 21 cents, following news Michael Thurn had been reappointed as the company’s managing director and chief executive officer.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options